Featured Research

from universities, journals, and other organizations

Molecular Doorway Holds Key To Gene Therapy

Date:
January 5, 1999
Source:
University Of North Carolina At Chapel Hill
Summary:
Molecular doorways on the surface of cells may be important factors in the success or failure of human gene therapy using altered viruses, according to researchers at the University of North Carolina at Chapel Hill.

CHAPEL HILL, N.C. -- Molecular doorways on the surface of cells may be important factors in the success or failure of human gene therapy using altered viruses, according to researchers at the University of North Carolina at Chapel Hill.

A report of their study published Jan. 4 in the journal Nature Medicine applies directly to a promising gene therapy method in which a harmless, genetically engineered virus called AAV (adeno-associated virus) is used to deliver genes into the body. The new findings tell us that the entry of AAV into the cell is facilitated by surface receptor molecules called alpha V beta 5-integrins. Without the presence of these integrins, the ability of AAV to "infect" the cell and deliver its genetic payload is diminished, say study authors led by Candace Summerford, doctoral student in pharmacology at the UNC-CH School of Medicine.

"We have been able to show that the virus interacts with two receptors: a primary receptor, which serves as an attachment molecule, and a secondary receptor -- the integrin co-factor -- that facilitates virus internalization," Summerford says. She notes that AAV is yet another example of a virus that uses multiple cell surface receptors to mediate its entry into cells. HIV, herpes simplex, and adenovirus, a cold virus, also employ multiple receptors.

The UNC-CH researchers tested hamster cell lines lacking the alpha-v beta5 integrin. Attempts at getting AAV into these cells proved far more difficult than those on cells that were genetically altered to express the integrin. "In the absence of integrin, the virus sits on the outside of the cell," says Dr. R. Jude Samulski, study senior author and director of the UNC-CH Gene Therapy Center. He points to micro-photographs of the virus glowing fluorescent red on the cell's surface. "This is the same cell where the integrin has been put in," Samulski says. He then refers to the next image in which the fluorescence is gone from the cell surface. "Within 10 minutes, the virus is taking a path to the cell nucleus."

Earlier work by Summerford identified the receptor for AAV that mediates attachment to the cell surface. This was the first step towards understanding how the virus infects the cell. Work done by her gene therapy colleagues has demonstrated that neurons carry this primary receptor for AAV, which probably explains why the AAV delivery of genes to the brain has proven very successful in recent experiments at the center. The new findings will help researchers better understand at the molecular level how the virus enters the cell.

The UNC-CH study not only helps clarify how AAV gets into cells, but also carries important implications for deciding which cells to target for human gene therapy using the virus.

"We will only have a high probability of successfully delivering genes to patient cells if the cells carry virus receptors," Samulski says. "The integrin story tells us that binding is the first step, internalization the second. Now that we know what's involved in bringing the virus into the cell, we can potentially exploit it."

Samulski refers to the next round of research on AAV as a viral vector -- the term used for a virus that carries a healthy gene into the body. "We want to change the virus so that it does something it's not evolved to do -- enter a cell that doesn't have the integrin receptor," he says.

The researcher and his colleagues are also gearing up to find ways to stimulate cells to produce more integrins on their surfaces, thus enhancing the chances of successful gene delivery. Summerford notes that white blood cells called monocytes can be removed from an individual and genetically induced to "express" a greater number of integrins on their surface. These cells may then be infected with AAV and re-infused into that individual.

"Before we can maximize the potential of any viral system for gene therapy, we have to understand the basic virology," she says. "How does the virus initiate infection, how does it attach to and enter the cell? And after it's in the cell, how does it get to the nucleus, and what regulates gene expression? These are very basic questions that need to be answered."

"We just figured out the first two steps of the journey: opening the door and stepping into the passageway," Samulski adds.


Story Source:

The above story is based on materials provided by University Of North Carolina At Chapel Hill. Note: Materials may be edited for content and length.


Cite This Page:

University Of North Carolina At Chapel Hill. "Molecular Doorway Holds Key To Gene Therapy." ScienceDaily. ScienceDaily, 5 January 1999. <www.sciencedaily.com/releases/1999/01/990105080056.htm>.
University Of North Carolina At Chapel Hill. (1999, January 5). Molecular Doorway Holds Key To Gene Therapy. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/1999/01/990105080056.htm
University Of North Carolina At Chapel Hill. "Molecular Doorway Holds Key To Gene Therapy." ScienceDaily. www.sciencedaily.com/releases/1999/01/990105080056.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins